STOCK TITAN

Ontrak Inc SEC Filings

OTRK NASDAQ

Welcome to our dedicated page for Ontrak SEC filings (Ticker: OTRK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Revenue tied to health-plan contracts, AI R&D costs, and HIPAA exposure make Ontrak’s disclosures challenging to unpack. If youve ever searched for Ontrak SEC filings explained simply, you already know that each 10-K blends behavioral-health outcomes with complex reimbursement language, while 8-Ks can move the stock on a single contract update.

Stock Titan solves that pain. Our platform streams every filing directly from EDGAR—then our AI turns dense text into plain-English highlights. Need the Ontrak annual report 10-K simplified? We point you to member enrollment metrics and PRE platform spend in seconds. Curious about cash flow shifts in the Ontrak quarterly earnings report 10-Q filing or want an Ontrak earnings report filing analysis? Key figures appear beside the document, already charted.

Real-time alerts flag Ontrak Form 4 insider transactions real-time, so you can track Ontrak executive stock transactions Form 4 the moment they hit EDGAR. Our dashboards connect every 8-K headline—Ontrak 8-K material events explained—to prior disclosures, while the Ontrak proxy statement executive compensation tab distills pay packages and performance goals. Whether youre monitoring Ontrak insider trading Form 4 transactions, comparing quarters, or understanding Ontrak SEC documents with AI, Stock Titan brings you:

  • AI-powered summaries that remove jargon
  • All filing types from 10-K to Form 4, updated in real time
  • Quick links to segment revenue, member trends, and risk factors

Stop wading through PDFs. Use Stock Titan to turn Ontrak’s regulatory disclosures into clear, actionable knowledge.

Filing
Rhea-AI Summary

Ontrak has received Notice of Effectiveness from the SEC for its Form S-1 registration statement (File No. 333-288099), which became effective on June 26, 2025 at 5:00 P.M. This Form S-1 effectiveness indicates that the company's registration statement for securities offering has been approved by the SEC.

Form S-1 is typically used for registering new securities offerings, suggesting that Ontrak is planning to conduct a public offering of securities. This development is significant for investors as it may indicate upcoming changes in the company's capital structure or funding status.

The effectiveness notice under CIK number 0001136174 means that Ontrak can now proceed with its planned securities offering, having satisfied the SEC's registration requirements and disclosure obligations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Schedule 13D/A filed for Ontrak, Inc. (OTRK) on 20 June 2025 discloses updated beneficial ownership positions for Terren S. Peizer and three affiliated entities—Acuitas Group Holdings LLC, Acuitas Capital LLC, and Humanitario Capital LLC. The filing is triggered by recent transactions that altered the group’s aggregate economic exposure through common stock, convertible notes and multiple warrant classes.

Key ownership figures

  • Terren S. Peizer: 68,013,532 shares beneficially owned, representing 97.5 % of the 69,793,767 fully-diluted shares the filer deems outstanding.
  • Acuitas Group Holdings LLC: 44,839,793 shares (91.6 % of 48,925,508 shares).
  • Acuitas Capital LLC: 15,055,568 shares (78.1 % of 19,273,416 shares).
  • Humanitario Capital LLC: 23,173,739 shares (92.4 % of 25,086,107 shares).

The majority of the reported shares are not currently outstanding common stock but are issuable under a complex structure of convertible demand notes, a surviving note, and several warrant classes: New Keep-Well Warrants (14.6 million shares), Demand Warrants (15.0 million), Conversion Warrants (7.5 million) and securities issued in a November 2023 private placement (20.9 million).

Implications for investors

  • The filings confirm that Peizer effectively controls Ontrak with near-total voting and dispositive power, limiting outside shareholder influence.
  • The large number of derivative securities indicates significant potential future dilution if the notes are converted and warrants exercised, pressuring per-share metrics.
  • Continued insider financing suggests access to capital, but reliance on a single investor heightens key-person and governance risk.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.05%
Tags
other
-
Rhea-AI Summary

Terren S. Peizer, a 10% owner of Ontrak (OTRK), reported significant insider transactions on June 20, 2025. Through Humanitario Capital LLC, Peizer acquired 500,000 shares of common stock at $0.0014 per share, bringing the total beneficial ownership to 2,305,480 shares.

Additionally, Peizer obtained 500,000 pre-funded common stock purchase warrants with an exercise price of $0.0014. These warrants, exercisable since December 20, 2023 until fully exercised, correspond to 500,000 underlying common shares. The total warrant position following the transaction stands at 799,575 warrants.

The filing was jointly submitted by Peizer and Acuitas Group Holdings, LLC, where Peizer serves as Chairman and sole member with complete voting and investment control. This transaction demonstrates continued insider investment in Ontrak at a notably low price point, potentially signaling confidence in the company's future prospects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.05%
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Ontrak, Inc. (ticker OTRK) reported insider activity through a Form 4 filed on 06/23/2025 covering transactions dated 06/18/2025. The filing is jointly submitted by Chairman Terren S. Peizer and his investment vehicle Acuitas Group Holdings, LLC, each identified as a 10 % beneficial owner of Ontrak’s equity.

Under the Sixth Amendment to the 2024 Master Note Purchase Agreement, an Acuitas-controlled entity purchased a $250,000 senior secured demand promissory note. The note is convertible at the holder’s option into Ontrak common stock at the lower of (i) $5.40 or (ii) the greater of the prevailing consolidated closing bid and $1.80 per share, subject to future adjustments. Because the principal is payable on demand, conversion could occur at any time, potentially adding common shares to the public float.

In addition to the note, Acuitas received a five-year warrant exercisable immediately for up to 359,712 common shares at an initial exercise price of $1.39 per share, also subject to adjustment. Following the warrant issuance, Acuitas reports beneficial ownership of 359,712 derivative securities. No open-market purchases or sales of Ontrak’s common stock were disclosed in Table I, and no cash exercise of the warrant has yet occurred. The transactions provide short-term financing to the company while simultaneously introducing potential dilution through the convertible note and warrant package.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ontrak has filed an S-1/A amendment for a reasonable best efforts public offering of up to 4,666,666 shares of common stock along with 18,666,664 warrants and up to 4,666,666 pre-funded warrants. The assumed combined offering price is $1.50 per share and four warrants.

Key offering details:

  • Each share comes with 4 warrants exercisable at a price to be determined, subject to stockholder approval
  • Pre-funded warrants ($0.0001 exercise price) available for investors who would exceed 4.99%/9.99% ownership
  • Warrants include price-based anti-dilution protection with a floor price of 20% of reference price
  • Roth Capital Partners engaged as exclusive placement agent
  • No minimum offering amount required; no escrow arrangements

Trading under symbol OTRK on Nasdaq Capital Market, with last closing price of $1.50 on June 11, 2025. Company is under Nasdaq discretionary panel monitor through October 7, 2025. Ontrak is classified as a smaller reporting company and non-accelerated filer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration

FAQ

What is the current stock price of Ontrak (OTRK)?

The current stock price of Ontrak (OTRK) is $0.5534 as of June 28, 2025.

What is the market cap of Ontrak (OTRK)?

The market cap of Ontrak (OTRK) is approximately 5.8M.

What is the primary focus of Ontrak Inc?

Ontrak Inc focuses on leveraging artificial intelligence to address behavioral health conditions that exacerbate chronic diseases. Its integrated care model combines predictive analytics and personalized interventions to improve patient outcomes.

How does the Ontrak PRE platform work?

The PRE platform operates by predicting patients likely to benefit from intervention, recommending personalized care pathways, and engaging individuals through both in-person and telehealth services. This structured approach ensures timely and effective healthcare delivery.

Which chronic conditions does Ontrak target?

Ontrak targets chronic conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. These conditions are managed with tailored, evidence-based interventions that integrate behavioral and medical care.

How does Ontrak integrate technology into its healthcare model?

The company integrates advanced AI algorithms and predictive analytics within its PRE platform to identify and engage patients in need. This is complemented by care coaching, telehealth services, and community care coordination to address the full spectrum of patient needs.

What differentiates Ontrak Inc from other healthcare companies?

Ontrak Inc differentiates itself by combining technology-driven insights with a robust, hybrid care delivery model. Its focus on both psychosocial and medical aspects of chronic disease management sets it apart in the competitive digital health landscape.

How does Ontrak ensure the effectiveness of its interventions?

Ontrak employs evidence-based methodologies integrated with real-time analytics to continuously refine its intervention strategies. This balanced approach ensures that recommended care pathways are data-driven and practically applicable to the patients’ needs.
Ontrak Inc

NASDAQ:OTRK

OTRK Rankings

OTRK Stock Data

5.82M
1.78M
45.97%
15.07%
1.47%
Health Information Services
Services-misc Health & Allied Services, Nec
Link
United States
MIAMI